Stoke Therapeutics, Inc.
STOK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $83 | $101 | $275 | $128 |
| Short-Term Investments | $165 | $146 | $83 | $89 |
| Receivables | $11 | $2 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $21 | $18 | $15 |
| Total Curr. Assets | $272 | $270 | $376 | $233 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $80 | $107 | $23 | $30 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $88 | $115 | $31 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $360 | $385 | $407 | $272 |
| Liabilities | – | – | – | – |
| Payables | $6 | $4 | $2 | $2 |
| Short-Term Debt | $3 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6 | $9 | $18 | $19 |
| Other Curr. Liab. | $27 | $23 | $22 | $16 |
| Total Curr. Liab. | $42 | $39 | $45 | $40 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $9 | $10 | $10 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $2 | $2 |
| Total NC Liab. | $10 | $11 | $12 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $2 | $2 | $2 |
| Total Liabilities | $52 | $50 | $57 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$440 | -$401 | -$378 | -$491 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $747 | $736 | $728 | $720 |
| Total Equity | $308 | $335 | $350 | $229 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $360 | $385 | $407 | $272 |
| Net Debt | -$80 | -$99 | -$272 | -$126 |